Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASE LID: ADS-5102 for Levodopa-Induced Dyskinesia in PD
NCT02136914Phase 3Completed
- Start
- May 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of amantadine in levodopa-induced dyskinesia (LID). Started May 2014; status: completed.
02
Drugs
amantadine
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT02136914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136914.